Cansino Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cansino Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cansino Biologics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
7.1414.6122.08
Details
Intrinsic
Valuation
LowReal ValueHigh
3.3510.8218.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cansino Biologics. Your research has to be compared to or analyzed against Cansino Biologics' peers to derive any actionable benefits. When done correctly, Cansino Biologics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cansino Biologics.

Cansino Biologics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Cansino Biologics and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Cansino and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Cansino Biologics does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Cansino Biologics Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Cansino OTC Stock performing well and Cansino Biologics company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Cansino Biologics' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 1.73  0.49  0.19  3.16  1.73  0.13 (1.84)  3.56 (2.97)  27.10 
MSFT 1.76 (0.23)  0.00 (0.10)  0.00 (0.08)  0.00  3.76 (3.86)  11.64 
UBER 2.77 (0.02)  0.00  0.05  3.29 (0.0026) (3.22)  8.60 (5.58)  19.67 
F 2.00 (0.17)  0.00 (0.05)  0.00 (0.0487)  0.00  2.75 (5.14)  14.93 
T 1.24  0.07  0.04  0.15  1.22  0.0344 (1.41)  2.54 (2.11)  9.13 
A 1.72  0.18  0.11  0.20  1.74  0.09 (2.03)  3.98 (3.59)  9.04 
CRM 2.27 (0.30)  0.00 (0.15)  0.00 (0.1)  0.00  3.63 (4.48)  14.31 
JPM 1.51  0.20  0.13  0.24  1.34  0.11 (1.63)  4.20 (2.88)  7.57 
MRK 1.07  0.25  0.17  0.58  1.04  0.16 (1.23)  2.44 (1.75)  7.38 
XOM 1.62  0.18  0.08  0.26  1.82  0.08 (1.72)  3.65 (2.91)  9.75 

Cansino Biologics Competitive Analysis

The better you understand Cansino Biologics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Cansino Biologics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Cansino Biologics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CAN
CYTR
 3.12 
 14.61 
 14.29 
 0.18 
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Current Liabilities
Total Asset
Last Dividend Paid
Short Ratio
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Cansino Biologics Competition Performance Charts

Complement your Cansino Biologics position

In addition to having Cansino Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corona Opportunity Thematic Idea Now

Corona Opportunity
Corona Opportunity Theme
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
View All  Next Launch
Continue to Cansino Biologics Correlation with its peers. Note that the Cansino Biologics information on this page should be used as a complementary analysis to other Cansino Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Cansino OTC Stock analysis

When running Cansino Biologics price analysis, check to measure Cansino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansino Biologics is operating at the current time. Most of Cansino Biologics' value examination focuses on studying past and present price action to predict the probability of Cansino Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cansino Biologics' price. Additionally, you may evaluate how the addition of Cansino Biologics to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Please note, there is a significant difference between Cansino Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cansino Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cansino Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CASBF
 Stock
  

USD 14.61  0.47  3.12%   

Cansino Biologics competes with CYTRX CORP; as well as few others. The company classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Analyzing Cansino Biologics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Cansino Biologics to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Cansino Biologics competition on your existing holdings. Continue to Cansino Biologics Correlation with its peers.